ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag stock market culture disease medicine

2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
The 2011 Labby Multimedia Awards
Jessica P. Johnson | Sep 1, 2011 | 6 min read
Introducing the winners of our second annual "Labbies" awards
Cell And Tissue Culture Techniques A Combination Of Science And Art
Holly Ahern | Dec 10, 1995 | 10 min read
Science And Art Author: Holly Ahern Cells of all types -- from organisms as simple as bacteria to those as complex as humans -- can be removed from representative tissues and grown in a culture vessel, where they reproduce and perform the same biological functions as cells in their natural state. When human skin cells such as fibroblasts are grown in culture, for example, they attach to the culture vessel and form a layer, just as if they were forming a layer of skin. Cultured fibroblasts secre
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Genentech Builds a Blockbuster-free Road to Billions
Susan Warner | Jun 6, 2004 | 8 min read
Courtesy of GenentechGenentech, the first US biotechnology company, has survived ugly patent disputes, product flops, and a Big Pharma partnership to become the biotech every company wants to be. The stock market value of the company, which makes the cancer drugs Herceptin and Rituxan, rose $7 billion (US), or 12%, in a single day in April based on promising data for a new lung-cancer treatment, Tarceva. That jump came less than a year after good results for Avastin in colon cancer trials sent t
Homelessness Should Be Treated As A Major Health Issue
William Breakey | Nov 9, 1997 | 6 min read
It is incongruous that in an era of great economic strength, with low unemployment, low inflation, a booming stock market, and high consumer optimism, a walk down the streets of any of our metropolises will reveal homeless people who are bedraggled, poor, and in many cases disabled by illness. It is all the more perturbing when one considers that these visibly destitute individuals, the sight of whom often offends the sensibilities of passersby, represent the mere tip of an iceberg of poverty
African Sleeping Sickness: A Recurring Epidemic
Ricki Lewis | May 12, 2002 | 5 min read
African trypanosomiasis is making an unwelcome comeback. But unlike other returning diseases, this one has a drug treatment—eflornithine—that disappeared from the market when it failed to cure cancer. Yet like Viagra's origin from a curious side effect in a clinical trial, so too was eflornithine reborn. "When it was discovered that it removes mustaches in women, it suddenly had a market: western women with mustaches," says Morten Rostrup, president of the international council for M
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
a mockup of an at-home COVID-19 test in development
Top Technical Advances of 2020
Shawna Williams | Dec 18, 2020 | 3 min read
The pandemic spurred innovation in a variety of ways, from CRISPR-based diagnostics to cell biology benchwork at home.

Run a Search

ADVERTISEMENT